{"success":true,"condition":"familial hypercholesterolemia","status_filter":"RECRUITING","phase_filter":"all","count":20,"trials":[{"nct_id":"NCT07473843","title":"Study of Zodasiran in Adolescent Participants With Homozygous Familial Hypercholesterolemia","status":"RECRUITING","phase":["PHASE3"],"sponsor":"Arrowhead Pharmaceuticals","interventions":["Zodasiran"],"enrollment":10,"url":"https://clinicaltrials.gov/study/NCT07473843"},{"nct_id":"NCT07465263","title":"A Study to Evaluate the SYH2053 Injection in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)","status":"RECRUITING","phase":["PHASE3"],"sponsor":"CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.","interventions":["SYH2053 Injection","Placebo Injection"],"enrollment":135,"url":"https://clinicaltrials.gov/study/NCT07465263"},{"nct_id":"NCT07421297","title":"A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed Hyperlipidemia","status":"RECRUITING","phase":["PHASE3"],"sponsor":"CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.","interventions":["SYH2053 injection","SYH2053 injection placebo"],"enrollment":760,"url":"https://clinicaltrials.gov/study/NCT07421297"},{"nct_id":"NCT04529967","title":"Child-Parent Familial Hypercholesterolemia Screening","status":"RECRUITING","sponsor":"Children's Hospital of Fudan University","interventions":["no interventions"],"enrollment":15000,"url":"https://clinicaltrials.gov/study/NCT04529967"},{"nct_id":"NCT02009345","title":"Familial Hypercholesterolemia Canada / Hypercholesterolemie Familiale Canada","status":"RECRUITING","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","interventions":[],"enrollment":6000,"url":"https://clinicaltrials.gov/study/NCT02009345"},{"nct_id":"NCT04370899","title":"Early Detection of Familial Hypercholesterolemia in Children","status":"RECRUITING","sponsor":"Institut Investigacio Sanitaria Pere Virgili","interventions":["lifestyle assessment"],"enrollment":400,"url":"https://clinicaltrials.gov/study/NCT04370899"},{"nct_id":"NCT06597006","title":"Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia","status":"RECRUITING","phase":["PHASE3"],"sponsor":"Novartis Pharmaceuticals","interventions":["Inclisiran","Placebo"],"enrollment":9,"url":"https://clinicaltrials.gov/study/NCT06597006"},{"nct_id":"NCT06743659","title":"Computerized Decision Support for Identification and Management of Familial Hypercholesterolemia","status":"RECRUITING","phase":["NA"],"sponsor":"Brigham and Women's Hospital","interventions":["Alert-based computerized decision support"],"enrollment":450,"url":"https://clinicaltrials.gov/study/NCT06743659"},{"nct_id":"NCT02208869","title":"Russian Familial Hypercholesterolemia Registry","status":"RECRUITING","sponsor":"Russian Cardiology Research and Production Center","interventions":[],"enrollment":1000,"url":"https://clinicaltrials.gov/study/NCT02208869"},{"nct_id":"NCT02693548","title":"The Spanish Familial Hypercholesterolaemia Cohort Study","status":"RECRUITING","sponsor":"Fundación Hipercolesterolemia Familiar","interventions":[],"enrollment":4141,"url":"https://clinicaltrials.gov/study/NCT02693548"},{"nct_id":"NCT07543731","title":"A Real-World Study of Long-Term Adherence and Persistence to Inclisiran, Evolocumab, and Alirocumab","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","interventions":[],"enrollment":5995,"url":"https://clinicaltrials.gov/study/NCT07543731"},{"nct_id":"NCT07614958","title":"Phase 3 Clinical Study Evaluating Efficacy, Safety, and Tolerability of Obicetrapib Vs Bempedoic Acid to Treat Dyslipidemia in Adults With Primary Non-familial Hypercholesterolemia or Mixed Dyslipidemia at High to Very High Cardiovascular Risk, During a Treatment Period of Approximately 84 Days","status":"RECRUITING","phase":["PHASE3"],"sponsor":"A. Menarini International Licensing S.A.","interventions":["Obicetrapib 10 mg/Bempedoic Acid Placebo","Bempedoic Acid 180mg/Placebo Obicetrapib"],"enrollment":426,"url":"https://clinicaltrials.gov/study/NCT07614958"},{"nct_id":"NCT05682378","title":"Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies","status":"RECRUITING","phase":["PHASE3"],"sponsor":"Novartis Pharmaceuticals","interventions":["Inclisiran"],"enrollment":195,"url":"https://clinicaltrials.gov/study/NCT05682378"},{"nct_id":"NCT07058077","title":"A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)","status":"RECRUITING","phase":["PHASE2","PHASE3"],"sponsor":"Merck Sharp & Dohme LLC","interventions":["Enlicitide Decanoate","Placebo"],"enrollment":153,"url":"https://clinicaltrials.gov/study/NCT07058077"},{"nct_id":"NCT06597019","title":"Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia","status":"RECRUITING","phase":["PHASE3"],"sponsor":"Novartis Pharmaceuticals","interventions":["Inclisiran","Placebo"],"enrollment":60,"url":"https://clinicaltrials.gov/study/NCT06597019"},{"nct_id":"NCT06125847","title":"NGGT006 Gene Therapy for Homozygous Familial Hypercholesterolemia","status":"RECRUITING","phase":["EARLY_PHASE1"],"sponsor":"First Affiliated Hospital Xi'an Jiaotong University","interventions":["NGGT006"],"enrollment":21,"url":"https://clinicaltrials.gov/study/NCT06125847"},{"nct_id":"NCT06960902","title":"Study of the Determinants of Coronary Atherosclerosis in Familial Hypercholesterolemia (ATHERO-FH Study)","status":"RECRUITING","phase":["NA"],"sponsor":"Nantes University Hospital","interventions":["Coronary CT scan with CAC score measurement"],"enrollment":600,"url":"https://clinicaltrials.gov/study/NCT06960902"},{"nct_id":"NCT07470723","title":"The ORIGIN-FH Study","status":"RECRUITING","phase":["NA"],"sponsor":"University of Wisconsin, Madison","interventions":["Screening for FH"],"enrollment":70,"url":"https://clinicaltrials.gov/study/NCT07470723"},{"nct_id":"NCT06439654","title":"Atlantic Lipid Lowering Treatment Optimization Program","status":"RECRUITING","phase":["NA"],"sponsor":"Atlantic Health System","interventions":["Supportive care"],"enrollment":250,"url":"https://clinicaltrials.gov/study/NCT06439654"},{"nct_id":"NCT06535542","title":"Integrating Whole Genome Sequencing and Digital Twins Into the Management of Hypercholesterolemia in Emiratis","status":"RECRUITING","phase":["NA"],"sponsor":"Abu Dhabi Health Services Company","interventions":["Whole Genome Sequencing"],"enrollment":40,"url":"https://clinicaltrials.gov/study/NCT06535542"}],"source":"ClinicalTrials.gov"}